ANDalyze makes good on its promise, as promised

Groundbreaking analytics startup ANDalyze, which Lux recommended to clients in our briefing (see the December 6, 2012 LRWJ) and gushed about in a follow-up analyst insight (see the December 20, 2012 LRWJ), has landed itself a major new partner. Hach, a division of Danaher and a major analytics pr...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

PacBio acquires Omniome in deal worth $800 million, expanding its DNA sequencing capabilities

News Commentary | August 02, 2021

PacBio specializes in long‑read DNA sequencing, which provides insights on genomic variants including immunology, rare diseases, and microbiology. The company seeks to complement its service by integrating Omniome's short‑read sequencing (SRS) platform, which can be utilized for cancer screening, ... Not part of subscription

Human Genomics

Tech Hub | August 25, 2021

The sequencing, analysis, and interpretation of the human genome, which leads to therapeutic, diagnostic, and wellness applications. Not part of subscription

Sequoia's new fund structure is good deal for investors; impact for entrepreneurs or corporate innovators is TBD – but likely not large

News Commentary | October 26, 2021

Famed venture firm Sequoia Capital is reorganizing to have one open‑ended parent "Sequoia Fund" over a variety of subfunds, some of which will remain typical closed‑ended venture funds while others invest in public markets or assets like crypto or pursue new models like registered investment ... To read more, click here.